Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA300903
Max Phase: Preclinical
Molecular Formula: C24H28O9
Molecular Weight: 460.48
Molecule Type: Small molecule
Associated Items:
ID: ALA300903
Max Phase: Preclinical
Molecular Formula: C24H28O9
Molecular Weight: 460.48
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Bipinnatin-H
Synonyms from Alternative Forms(1):
Canonical SMILES: CC(=O)O[C@H]1C[C@H](C2(C)CO2)[C@@H](OC(C)=O)c2oc(cc2C)[C@@H]2O[C@@]2(C)C[C@@H]2C=C1C(=O)O2
Standard InChI: InChI=1S/C24H28O9/c1-11-6-18-21-23(4,33-21)9-14-7-15(22(27)31-14)17(29-12(2)25)8-16(24(5)10-28-24)20(19(11)32-18)30-13(3)26/h6-7,14,16-17,20-21H,8-10H2,1-5H3/t14-,16-,17-,20+,21-,23-,24?/m0/s1
Standard InChI Key: ZKPQWDXTJKFKDU-SZTWMKIDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 460.48 | Molecular Weight (Monoisotopic): 460.1733 | AlogP: 3.00 | #Rotatable Bonds: 3 |
Polar Surface Area: 117.10 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.84 | CX Basic pKa: | CX LogP: 1.59 | CX LogD: 1.59 |
Aromatic Rings: 1 | Heavy Atoms: 33 | QED Weighted: 0.38 | Np Likeness Score: 2.76 |
1. Abramson SN, Trischman JA, Tapiolas DM, Harold EE, Fenical W, Taylor P.. (1991) Structure/activity and molecular modeling studies of the lophotoxin family of irreversible nicotinic receptor antagonists., 34 (6): [PMID:1676426] [10.1021/jm00110a007] |
Source(1):